WIXOM, MI--(Marketwired - Jun 18, 2013) - Rockwell Medical ( NASDAQ : RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the ...
WIXOM, MI -- (Marketwired) -- 05/20/13 -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the ...
WIXOM, MI -- (Marketwired) -- 05/29/13 -- Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment ...
Rockwell Medical Inc. (NASDAQ:RMTI) shares gained 2.27 percent to $3.60 in post-market trading. The company announced on Monday the closing of the sale of 13,196,721 common shares, including 1,721,311 common shares to cover over-allotments, ...
Jun 19, 2013 (Menafn - M2 EQUITYBITES via COMTEX) --Biopharmaceutical company Rockwell Medical RMTI revealed on Tuesday the completion of a USD20m debt financing with Hercules Technology Growth Capital Inc. This USD20m straight-debt ...
Boston, MA 05/22/2013 (wallstreetpr) - The share prices of Rockwell Medical Inc. (NASDAQ:RMTI) surged by 9.94 percent to close at $3.87 per share for the trading day.
Jun 19, 2013 (Menafn - M2 EQUITYBITES via COMTEX) --Rockwell Medical RMTI, a fully-integrated biopharmaceutical company, announced on Tuesday the closing of a USD20m debt financing with Hercules Technology Growth Capital Inc, a specialty ...
Latest news and deals relating to the products. Companies Involved in Iron Deficiency Anemia Therapeutics Development -- AMAG Pharmaceuticals, Inc. -- Rockwell Medical Technologies, Inc. -- Galenica Ltd. -- Panion & Bf Biotech Inc. -- Vifor Pharma Ltd.
JUNE 20�Duquesne University's School of Leadership and Professional Advancement will host the �Adult Student Information Webinar: Graduate Programs� from 12-12:30 p.m.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.